iThe current values are delayed, open demat account for live values.
Nifty Pharma
Nifty Pharma Performance
-
Open
21,672.05
-
High
21,857.85
-
Low
21,552.90
-
Prev Close
21,768.85
-
Dividend Yeild
0.63%
-
P/E
34.38
Nifty Pharma Chart
Stocks Performance
Color code for Stocks Performance
- 5% and above
- 5% to 2%
- 2% to 0.5%
- 0.5% to -0.5%
- -0.5% to -2%
- -2% to -5%
- -5% and below
Constituent Companies
| Company | Market Cap | Market Price | Volume | Sector |
|---|---|---|---|---|
| Abbott India Ltd | ₹57787 Cr |
₹26982
(1.51%)
|
11981 | Pharmaceuticals |
| Cipla Ltd | ₹118826 Cr |
₹1466.9
(0.88%)
|
1988607 | Pharmaceuticals |
| J B Chemicals & Pharmaceuticals Ltd | ₹25874 Cr |
₹1692.8
(0.73%)
|
196457 | Pharmaceuticals |
| Dr Reddys Laboratories Ltd | ₹101290 Cr |
₹1198.85
(0.66%)
|
702197 | Pharmaceuticals |
| Lupin Ltd | ₹92929 Cr |
₹2051.1
(0.39%)
|
1136625 | Pharmaceuticals |
Nifty Pharma Sector Performance
Top Performing
| Sector Name | Percentage Change |
|---|---|
| Healthcare | 0.25 |
| Financial Services | 0.28 |
| Infrastructure Investment Trusts | 0.24 |
| Printing & Stationery | 0.18 |
Under Performing
| Sector Name | Percentage Change |
|---|---|
| Diamond, Gems and Jewellery | -1.19 |
| IT - Hardware | -1.12 |
| Leather | -0.38 |
| Ceramic Products | -0.4 |
Nifty Pharma
Nifty Pharma index is a stock market index that tracks the performance of the top pharmaceutical companies listed on National Stock Exchange in India. It includes companies involved in the development, manufacturing, and marketing of drugs and healthcare products. Investors use Nifty Pharma index to gauge the health of the pharmaceutical sector and to make investment decisions. A rising index indicates strong performance by these companies while a falling index might signal challenges or weaker performance in the sector. It's a key indicator for those interested in the Indian pharmaceutical industry.
NIFTY Pharma Index was launched on 1 July 2005 and initially included only 10 stocks. Since 30 September 2021, it has expanded to 20 tradable pharmaceutical stocks listed on the exchange. NIFTY Pharma index includes companies involved in biotechnology and pharmaceuticals. It is rebalanced twice a year to reflect changes in the Indian healthcare industry. Managed by NSE Indices Limited formerly India Index Services & Products Limited, the index is overseen by a three tier system Board of Directors, Index Advisory Committee and Index Maintenance Sub Committee. Additionally, there is a variant called NIFTY Pharma Total Returns Index.
What is the Nifty Pharma Index?
NIFTY Pharma Index launched on 1 July 2005 tracks the performance of the pharmaceutical sector in India. Initially comprising 10 stocks, it expanded to 20 tradable stocks from 30 September 2021. NIFTY Pharma index includes companies involved in biotechnology and pharmaceuticals. It started with a base value of 1000 based on 1 January 2001. Managed by NSE Indices Limited, the index is updated semi annually to reflect changes in the healthcare industry. There is also a variant, the NIFTY Pharma Total Returns Index.
How is the Nifty Pharma Index Value Calculated?
Nifty Pharma Index value is calculated using the formula
Index Value = Current Market Capitalization / (Base Market Capitalization * Base Index Value).
This index is updated twice a year with adjustments based on data up to 31 January and 31 July. If there are changes in the companies included in the index these are announced four weeks in advance and take effect on the last trading day of March and September. This process ensures the index accurately reflects the performance of leading pharmaceutical companies in the market.
Nifty Pharma Scrip Selection Criteria
Nifty Pharma Index is made up of 20 pharmaceutical stocks, chosen based on their market value adjusted for how freely their shares are traded. To be included, a stock must meet several criteria:
1. It must be listed on National Stock Exchange.
2. It must be part of Nifty 500 index.
3. If there aren't enough eligible stocks, additional ones are picked from the top 800 stocks based on trading activity and market value from Nifty 500 list.
4. It must be from the pharmaceutical sector.
5. It should have traded at least 90% of the time over the past six months.
6. It must have been listed for at least six months.
7. Ideally, it should be traded on NSE’s Futures & Options segment.
8. Newly listed companies can be included if they meet these criteria for at least three months.
9. No single stock should make up more than 33% of the index and top three stocks combined should not exceed 62% of the index.
How does Nifty Pharma work?
Nifty Pharma is an index on National Stock Exchange that tracks the performance of major pharmaceutical companies in India. It includes top pharma stocks based on market capitalization and liquidity. Nifty Pharma index reflects the overall health of the pharmaceutical sector, showing how well these companies are performing. Investors use it to gauge sector trends, make investment decisions and compare the performance of individual pharma stocks against the broader market. When the index goes up, it means the pharma sector is doing well and vice versa.
What are the Benefits of Investing in the Nifty Pharma?
Investing in Nifty Pharma index offers several benefits. It provides exposure to leading pharmaceutical companies in India allowing you to tap into the growing healthcare sector. Nifty Pharma index includes firms with strong fundamentals and consistent performance. By investing in Nifty Pharma, you gain diversification within the pharma sector reducing the risk associated with individual stocks. Additionally, the pharmaceutical industry usually benefits from increasing healthcare demands and advancements in medical technology, potentially leading to steady returns. This makes Nifty Pharma a promising option for those looking to invest in a crucial and expanding sector.
What is the History of the Nifty Pharma?
NIFTY Pharma index launched on 1 July 2005 with a base value of 1000 from 1 January 2001, tracks major pharmaceutical companies in India. As of September 2024 Nifty Pharma Index current price is 23,256.85. It’s updated twice a year to stay current with the pharmaceutical industry's changes. Managed by NSE Indices Limited, Nifty pharma index has a governance structure that includes a Board of Directors, Advisory Committee and a Maintenance Sub Committee. There's also a variant called NIFTY Pharma Total Returns Index.
Other Indices
| Indices Name | Price | Price Change (% change) |
|---|---|---|
| India VIX | 15.5525 | -0.11 (-0.69%) |
| Nifty 10 Yr Benchmark G-Sec | 2413.64 | -2.11 (-0.09%) |
| Nifty 10 Yr Benchmark G-Sec (Clean Price) | 886.09 | -0.78 (-0.09%) |
| Nifty 100 | 24134.15 | -240.55 (-0.99%) |
| Nifty 100 Equal Weight | 30736 | -531.1 (-1.7%) |
Faqs
How To Invest in Nifty Pharma Stocks?
You can invest in the NIFTY Pharma index through various methods:
1. Direct Investment: Use a trading account to buy individual stocks from the NIFTY Pharma index.
2. Exchange Traded Derivatives: Engage in futures and options contracts based on NIFTY Pharma index.
3. Exchange Traded Funds: ETFs aim to replicate the total returns of the NIFTY Pharma index accounting for tracking errors.
4. Index Mutual Funds: Some mutual funds focus on pharmaceutical companies and track the index though they may have high expense ratios.
What are Nifty pharma stocks?
Nifty Pharma stocks are shares of major pharmaceutical companies listed on NIFTY Pharma index. These companies are selected for their role in India's pharma sector, reflecting their impact on the industry's performance and growth. Examples include Sun Pharma, Dr. Reddy's Laboratories and Cipla.
Can you trade shares on Nifty Pharma?
Yes, you can trade shares of companies listed in the Nifty Pharma Index through a Demat account. You can also invest in ETFs or index funds that track the index for broader exposure to the Pharma sector.
In which year was the Nifty Pharma Index launched?
Nifty Pharma Index was launched on 1 July 2005 by NSE Indices Limited to track the performance of India's Pharma sector.
Can we buy Nifty Pharma and sell it tomorrow?
Yes, you can buy Nifty Pharma stocks and sell them the next day, following the BTST (Buy Today, Sell Tomorrow) strategy. This allows you to take advantage of short term price movements without waiting for the usual settlement period.
Latest News
- Nov 21, 2024
Zinka Logistics IPO (Blackbuck IPO) Company Profile Zinka Logistics Solution Limited, known for its digital platform BlackBuck, brings a unique investment opportunity to India’s logistics sector. Zinka IPO, totalling ₹1,114.72 crores, includes a fresh issue of 2.01 crore shares worth ₹550.00 crores and an offer for sale of 2.07 crore shares worth ₹564.72 crores.
- Nov 21, 2024
Our analysts at 5paisa scan through the financial markets and select the few trending stocks in the news and in the limelight for the day. Here is the list of a few trending stocks with their latest News and Updates.
- Nov 19, 2024
ICL Fincorp is a non-deposit-taking, base-layer Non-Banking Financial Company (NBFC) specializing in gold loans, where money is lent against the pledge of household gold ornaments. The company operates primarily in Kerala, Tamil Nadu, Andhra Pradesh, Karnataka, Telangana, Odisha, Gujarat, and Maharashtra.
- Nov 19, 2024
Indian equity markets closed in the red on November 19, recovering from the previous session's losses. Positive cues from Asian markets and easing foreign institutional investor (FII) outflows helped indices bounce back, although late-session selling erased part of the gains. The Nifty 50 ended above the 23,500 mark, while the Sensex gained 239 points.
Latest Blogs
Summary Zinka Logistics IPO has closed with moderate response from investors, achieving a subscription of 1.87 times by 18th November 2024 at 5:21:08 PM (Day 3). The public issue witnessed varied demand across categories. The Employee portion led with strong interest at 9.87 times subscription. The Qualified Institutional Buyers (QIB) showed decent interest with 2.72 times subscription.
- Nov 21, 2024
Nifty Prediction for 21st November The Nifty index broke its seven-day losing streak, closing above the 23,500 mark with slight gains. After opening on a positive note, the benchmark indices maintained upward momentum for most of the session. However, late selling pressure eroded earlier gains, and the Nifty ultimately settled at 23,518, up by 64.70 points.
- Nov 21, 2024
Highlights 1. Federal shares saw a marginal rise, trading at ₹ 197.60 with an intraday high of ₹ 198.00. 2. The federal stock price remains resilient, nearing its 52-week high of ₹ 209.75 amidst market volatility. 3. Brokerages project the federal share price to reach ₹ 240 in the next 2-3 quarters, signaling strong growth potential.
- Nov 19, 2024
Summary Onyx Biotec IPO has closed with an extraordinary response from investors, achieving a remarkable subscription of 198.00 times by 18th November 2024 at 5:15:59 PM (Day 3). The public issue witnessed overwhelming demand across all categories. The Non-Institutional Investors (NII) category led with an exceptional subscription of 602.86 times. The Retail Investors segment showed strong enthusiasm with 118.26 times subscription.
- Nov 19, 2024
